During a conversation with Dexcom's CEO, various advancements in continuous glucose monitoring (CGM) technology were discussed, hinting at potential future uses.
The CEO provided updates on the WiSeR initiative, which may have significant implications for health monitoring practices.
Additionally, there was an analysis of Epic's market share within the health tech sector, reflecting the competitive landscape of the industry.